Athletics: Olympic champion and high hurdles world record holder Aries Merritt will have a kidney transplant next week after competing in the World Championships in Beijing, the 30-year-old American said. Merritt, who was told he would never run again after being diagnosed with kidney disease in 2013, set the second fastest time behind compatriot David Oliver in the heats of the 110 metres hurdles yesterday. The disease, caused by a rare genetic disorder found predominantly in African Americans, has damaged his organ to such an extent that he will receive one of his sister’s kidneys in Arizona on September 1.

Tennis: Caroline Wozniacki breezed into the second round of the Connecticut Open as she dispatched American wildcard Alison Riske in less than an hour. Wozniacki, seeded third, won the first seven games en route to a 6-0 6-2 win in just 58 minutes. “I know she’s beaten Top 10 players before, so I went into this match knowing I had to stay close to the baseline, get a lot of returns deep and just not let her into the match,” Wozniacki said. “I think I played really well. I’m definitely happy with my performance.” The win saw Wozniacki improve to 25-3 at this tournament, having won the title in 2008, 2009, 2010 and 2011.

Motor Racing: Audi have been fined €200,000 and their motor sports chief has been banned from the DTM garages until the end of the season after he urged his driver Timo Scheider to cause a collision, the German motor sports federation court ruled yesterday. Scheider, who has to sit out the series’ next race in Russia starting this week, was ordered by Wolfgang Ullrich during the race in Spielberg to push a rival driving a Mercedes out of the way which he did, forcing two vehicles out of the race. “Timo push him out,” Ullrich is heard saying. The motor sports chief has also been banned from using the team radio.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.